Mallinckrodt Inc., a prominent player in the pharmaceutical industry, is headquartered in New York, USA. Founded in 1867, the company has established itself as a leader in specialty pharmaceuticals, particularly in pain management and autoimmune disorders. With a strong operational presence across North America and Europe, Mallinckrodt focuses on developing innovative therapies that address unmet medical needs. The company’s core products include a range of prescription medications and specialty treatments, distinguished by their efficacy and safety profiles. Notable achievements include the successful launch of several groundbreaking therapies that have significantly improved patient outcomes. As a trusted name in the healthcare sector, Mallinckrodt Inc. continues to enhance its market position through a commitment to research and development, ensuring it remains at the forefront of pharmaceutical advancements.
We don't have data for Mallinckrodt Inc. (New York), but we can show you information about their parent organization instead.
View parent company